1. Home
  2. Live Updates
  3. Joyce allaire

Live Breaking News & Updates on Joyce allaire

Stay informed with the latest breaking news from Joyce allaire on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Joyce allaire and stay connected to the pulse of your community

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Virginia , United-states , Chicago , Illinois , Massachusetts , Mccormick-place , American , Joyce-allaire , Hall , Aparna-parikh , Alex-spira , Mccormick-place-convention-center

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Boston , Massachusetts , Chicago , Illinois , American , Joyce-allaire , Shiraj-sen , Michael-biega , Sensei-biotherapeutics , Exchange-commission , Nasdaq

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose ...

BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today

Boston , Massachusetts , United-states , Chicago , Illinois , American , Michael-biega , Shiraj-sen , Sensei-biotherapeutics , Joyce-allaire , Exchange-commission , American-society-of-clinical-oncology

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024

Sagimet announced positive topline data from its FASCINATE-2 Phase 2b clinical trial of denifanstat in MASH in January 2024 and plans to initiate Phase 3 trial in the second half of 2024SAN MATEO,...

Brooke-army-medical-center , Texas , United-states , San-antonio , Joyce-allaire , Sagimet-biosciences , Stephen-harrison , Saint-louis-university , Exchange-commission , Summit-clinical-research , University-of-oxford , Nasdaq

Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™

Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001) through six months, with...

United-states , American , Rabia-gurses-ozden , Donald-notman , Pravin-dugel , Mark-gallardo , Joyce-allaire , Allergan , Exchange-commission , American-society-of-cataract , Ocular-therapeutix-inc , Linkedin

Ocular Therapeutixtm Announces Positive Phase 2 PAXTRAVATM Glaucoma Data At The American Society Of Cataract And Refractive Surgery 2024 Annual Meetin...

Ocular Therapeutixtm Announces Positive Phase 2 PAXTRAVATM Glaucoma Data At The American Society Of Cataract And Refractive Surgery 2024 Annual Meetin...
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Pravin-dugel , Mark-gallardo , Joyce-allaire , Rabia-gurses-ozden , Donald-notman , Ocular-therapeutix-inc , Allergan , Linkedin , Exchange-commission , Intraocular-pressure , Chief-medical-officer , Study-investigator

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Michael-biega , Joyce-allaire , Sensei-biotherapeutic , Robert-schreiber , Sensei-biotherapeutics , Sensei-bio , Louis-school-of-medicine , Exchange-commission , Sensei-biotherapeutics-inc

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

BRISBANE, Calif., April 03, 2024 -- Annexon, Inc. , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical...

Brisbane , Queensland , Australia , Joyce-allaire , Sheryl-seapy , Lifesci-advisors , Annexon-inc , Nasdaq , Douglas-love , Annual-needham-virtual-healthcare-conference , Sci-advisors ,

Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress

72-week data of atacicept in IgAN accepted as a best-ranked abstract

Stockholm , Sweden , Germany , Brisbane , Queensland , Australia , Mari-purpura , Joyce-allaire , Richard-lafayette , Nasdaq , Exchange-commission , Vera-therapeutics-inc

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Lauren-walker , Alex-gray , Joyce-allaire , Jasper-therapeutics-inc , Nasdaq , Annual-needham-virtual-healthcare , Annual-needham-virtual-healthcare-conference , Investor-relations , Each-option , Jasper-therapeutics , Equity-incentive-plan